62 related articles for article (PubMed ID: 38683607)
1. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis.
Daher D; Seif El Dahan K; Cano A; Gonzales M; Ransom C; Jaurez E; Carranza O; Quirk L; Morgan T; Gopal P; Patel MS; Lieber S; Louissaint J; Cotter TG; VanWagner LB; Yang JD; Parikh ND; Yopp A; Rich NE; Singal AG
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):295-304.e2. PubMed ID: 37573986
[TBL] [Abstract][Full Text] [Related]
3. Proportion of Time Covered by Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis.
Daher D; Seif El Dahan K; Yekkaluri S; Gopal P; Rich NE; Parikh ND; Murphy CC; Singal AG
Am J Gastroenterol; 2024 May; 119(5):875-882. PubMed ID: 37975606
[TBL] [Abstract][Full Text] [Related]
4. Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.
Wun YT; Dickinson JA
Cochrane Database Syst Rev; 2003; (2):CD002799. PubMed ID: 12804438
[TBL] [Abstract][Full Text] [Related]
5. Screening for hepatocellular carcinoma in chronic liver disease: a systematic review.
Kansagara D; Papak J; Pasha AS; O'Neil M; Freeman M; Relevo R; Quiñones A; Motu'apuaka M; Jou JH
Ann Intern Med; 2014 Aug; 161(4):261-9. PubMed ID: 24934699
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients.
Daher D; Seif El Dahan K; Rich NE; Tayob N; Merrill V; Huang DQ; Yang JD; Kulkarni AV; Kanwal F; Marrero J; Parikh N; Singal AG
JAMA Netw Open; 2024 Apr; 7(4):e248755. PubMed ID: 38683607
[TBL] [Abstract][Full Text] [Related]
7. Improved Survival of Hepatocellular Carcinoma Patients Diagnosed with a Dedicated Screening Programme-a Propensity Score Adjusted Analysis.
Chinnaratha MA; Campbell K; Mathias R; McCormick RJ; Woodman RJ; Wigg AJ
J Gastrointest Cancer; 2019 Dec; 50(4):888-893. PubMed ID: 30345486
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US.
Singal AG; Mittal S; Yerokun OA; Ahn C; Marrero JA; Yopp AC; Parikh ND; Scaglione SJ
Am J Med; 2017 Sep; 130(9):1099-1106.e1. PubMed ID: 28213044
[TBL] [Abstract][Full Text] [Related]
9. No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis.
Moon AM; Weiss NS; Beste LA; Su F; Ho SB; Jin GY; Lowy E; Berry K; Ioannou GN
Gastroenterology; 2018 Oct; 155(4):1128-1139.e6. PubMed ID: 29981779
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis.
Choi DT; Kum HC; Park S; Ohsfeldt RL; Shen Y; Parikh ND; Singal AG
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):976-987.e4. PubMed ID: 30616961
[TBL] [Abstract][Full Text] [Related]
11. Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening.
Tseng PL; Wang JH; Tung HD; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen PF; Tsai LS; Lu SN
J Gastroenterol Hepatol; 2010 Aug; 25(8):1426-34. PubMed ID: 20659234
[TBL] [Abstract][Full Text] [Related]
12. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy.
Singal AG; Kanwal F; Llovet JM
Nat Rev Clin Oncol; 2023 Dec; 20(12):864-884. PubMed ID: 37884736
[TBL] [Abstract][Full Text] [Related]
13. Financial Burden of Hepatocellular Carcinoma Screening in Patients With Cirrhosis.
Narasimman M; Hernaez R; Cerda V; Lee M; Yekkaluri S; Khan A; Sood A; Gurley T; Quirk L; Liu Y; Kramer JR; Lee SC; Tiro JA; Murphy CC; Singal AG
Clin Gastroenterol Hepatol; 2024 Apr; 22(4):760-767.e1. PubMed ID: 37544418
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis.
Narasimman M; Hernaez R; Cerda V; Lee M; Sood A; Yekkaluri S; Khan A; Quirk L; Liu Y; Kramer JR; Craddock Lee S; Murphy CC; Tiro JA; Singal AG
Hepatology; 2024 Jan; 79(1):107-117. PubMed ID: 37401857
[TBL] [Abstract][Full Text] [Related]
15. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Singal AG; Llovet JM; Yarchoan M; Mehta N; Heimbach JK; Dawson LA; Jou JH; Kulik LM; Agopian VG; Marrero JA; Mendiratta-Lala M; Brown DB; Rilling WS; Goyal L; Wei AC; Taddei TH
Hepatology; 2023 Dec; 78(6):1922-1965. PubMed ID: 37199193
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
